Journal of Antimicrobial Chemotherapy (2001) 48, 391-396
© 2001 The British Society for Antimicrobial Chemotherapy
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, ß-lactamase activity and RiboPrinting
a Panum Institute, Institute for Medical Microbiology and Immunology 24.1, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N; b Department of Gastrointestinal Infections, Statens Serum Institut; c Danish Cystic Fibrosis Centre; d Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
The purpose of this study was to characterize 42 paired mucoid and non-mucoid Danish cystic fibrosis (CF) Pseudomonas aeruginosa isolates collected in 1997, by RiboPrinting, antibiotic susceptibility and ß-lactamase activity. Eight P. aeruginosa isolates collected before 1991 were included for comparison. Eighteen of the 42 paired mucoid and non-mucoid isolates showed the same ribotype; the remaining 24 belonged to different ribogroups. Mucoid isolates showed higher susceptibility to antibiotics and lower ß-lactamase activity compared with non-mucoid isolates. Significant differences (P 0.01) between mucoid and non-mucoid isolates were found for the meropenem and colistin MICs for the isolates with the same ribotype, and for the MICs of ceftazidime, piperacillin, aztreonam, meropenem, tobramycin, ciprofloxacin and in the basal levels of ß-lactamase for the paired isolates belonging to different ribogroups. A dominant ribotype 73-S2 with hyperinducible ß-lactamase production and significantly higher MICs of piperacillin, meropenem and tobramycin compared with the other major ribotypes (73-S1, 207-S3 and 227-S8) was present among the 84 CF isolates. The isolates collected before 1991 had an antibiotic susceptibility pattern similar to the 1997 isolates. Despite prolonged and intensive antibiotic treatment, susceptible mucoid isolates were isolated from the CF sputum, possibly because these bacteria are protected from the selective pressure of antibiotics by the resistant non-mucoid isolates co-existing in the biofilm in the lungs of CF patients.
* Corresponding author. Tel: +45-3532-7899; Fax: +45-3532-7693; E-mail: O.Ciofu{at}immi.ku.dk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Yang, J. A. J. Haagensen, L. Jelsbak, H. K. Johansen, C. Sternberg, N. Hoiby, and S. Molin In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections J. Bacteriol., April 15, 2008; 190(8): 2767 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Southey-Pillig, D. G. Davies, and K. Sauer Characterization of Temporal Protein Production in Pseudomonas aeruginosa Biofilms J. Bacteriol., December 1, 2005; 187(23): 8114 - 8126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lee, J. A. J. Haagensen, O. Ciofu, J. B. Andersen, N. Hoiby, and S. Molin Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis J. Clin. Microbiol., October 1, 2005; 43(10): 5247 - 5255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bagge, M. Hentzer, J. B. Andersen, O. Ciofu, M. Givskov, and N. Hoiby Dynamics and Spatial Distribution of {beta}-Lactamase Expression in Pseudomonas aeruginosa Biofilms Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|